COVID-19

Research explores how people with traumatic brain injury have adapted to the pandemic

The Department of Hearing and Speech Sciences has conducted research to better understand how individuals with traumatic brain injury (TBI) have adapted to the COVID-19 pandemic. Researchers think the findings may apply to many disability populations in future crises.

Heparin, platelets discouraged as treatment for blood clots after COVID vaccine

Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.

Brad Paisley stars in new VUMC public service announcement urging people to “take the shot”

A simple message that can save lives and help life get back to normal

VUMC to lead national study to treat severe COVID complications

The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.

Jeff Balser, MD, PhD, discusses VUMC’s commitment to community during this week’s Leadership Assembly.

Flexibility, trust: Takeaways from Leadership Assembly

The flexibility and adaptability of Vanderbilt University Medical Center has been center stage as the pressures of COVID-19 and ongoing strategic imperatives have transformed how and where care is delivered.

VUMC team screens high school for SARS-CoV-2 asymptomatic infections

Under the SARS CoV-2 Return to School Saliva Opt-in Screening Study, which began last November at University School of Nashville, a research team from Vanderbilt University Medical Center is testing a solution for efficient asymptomatic disease surveillance and control.

1 11 12 13 14 15 36